# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA672884 | F | Compound was tested for growth inhibition of Don-6 cell lines at 0.1 mM concentration | Cricetulus griseus | 2 | ALA1121845 | cell-based format | Scientific Literature | |
2. | ALA672885 | F | Growth inhibition of Don-6 cell lines at 1.0 mM concentration | Cricetulus griseus | 16 | ALA1121845 | cell-based format | Scientific Literature | |
3. | ALA741912 | F | Compound was tested for antitumor activity against the B-16 melanoma in mice at dose of 100(mg/kg)/day intraperitoneally per day | Mus musculus | 1 | ALA1121845 | organism-based format | Scientific Literature | |
4. | ALA741344 | F | Compound was tested for antitumor activity against the B-16 melanoma in mice at dose of 300(mg/kg)/day intraperitoneally per day | Mus musculus | 1 | ALA1121845 | organism-based format | Scientific Literature | |
5. | ALA741346 | F | Compound was tested for antitumor activity against the B-16 melanoma in mice at dose of 500(mg/kg)/day intraperitoneally per day | Mus musculus | 2 | ALA1121845 | organism-based format | Scientific Literature | |
6. | ALA741348 | F | Compound was tested for antitumor activity against the L1210 leukemia in mice at dose of 100(mg/kg)/day intraperitoneally per day | Mus musculus | 2 | ALA1121845 | organism-based format | Scientific Literature | |
7. | ALA741352 | F | Compound was tested for antitumor activity against the L1210 leukemia in mice at dose of 300(mg/kg)/day intraperitoneally per day | Mus musculus | 1 | ALA1121845 | organism-based format | Scientific Literature | |
8. | ALA741354 | F | Compound was tested for antitumor activity against the L1210 leukemia in mice at dose of 500(mg/kg)/day intraperitoneally per day | Mus musculus | 2 | ALA1121845 | organism-based format | Scientific Literature | |
9. | ALA745162 | F | Compound was tested for antitumor activity against the B-16 melanoma in mice at dose of 100(mg/kg)/day intraperitoneally per day | Mus musculus | 1 | ALA1121845 | organism-based format | Scientific Literature | |
10. | ALA744636 | F | Compound was tested for antitumor activity against the B-16 melanoma in mice at dose of 300(mg/kg)/day intraperitoneally per day | Mus musculus | 1 | ALA1121845 | organism-based format | Scientific Literature | |
11. | ALA744638 | F | Compound was tested for antitumor activity against the B-16 melanoma in mice at dose of 500(mg/kg)/day intraperitoneally per day | Mus musculus | 2 | ALA1121845 | organism-based format | Scientific Literature | |
12. | ALA744640 | F | Compound was tested for antitumor activity against the L1210 leukemia in mice at dose of 100(mg/kg)/day intraperitoneally per day | Mus musculus | 2 | ALA1121845 | organism-based format | Scientific Literature | |
13. | ALA743880 | F | Compound was tested for antitumor activity against the L1210 leukemia in mice at dose of 300(mg/kg)/day intraperitoneally per day | Mus musculus | 1 | ALA1121845 | organism-based format | Scientific Literature | |
14. | ALA743882 | F | Compound was tested for antitumor activity against the L1210 leukemia in mice at dose of 500(mg/kg)/day intraperitoneally per day | Mus musculus | 1 | ALA1121845 | organism-based format | Scientific Literature | |
15. | ALA822469 | F | Compound was tested for growth inhibition of YT-nu cell lines at 0.1 mM concentration | Homo sapiens | 2 | ALA1121845 | cell-based format | Scientific Literature | |
16. | ALA822470 | F | Growth inhibition of YT-nu cell lines at 1.0 mM concentration | Homo sapiens | 16 | ALA1121845 | cell-based format | Scientific Literature |